Results 21 to 30 of about 124,123 (208)

Effects of chlorthalidone and diltiazem on myocardial ischemia in elderly patients with hypertension and coronary artery disease

open access: yesArquivos Brasileiros de Cardiologia, 2001
OBJETIVE: Antihypertensive therapy with thiazides decreases coronary events in elderly patients. However, the influence of diuretics on myocardial ischemia has not been fully investigated. The aim of this study was to compare the effect of chlorthalidone
João Batista Serro-Azul   +9 more
doaj   +1 more source

Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundGuidelines for hypertension vary in their preference for initial combination therapy or initial monotherapy, stratified by patient profile; therefore, we compared the efficacy and tolerability of these approaches.
Thomas M. MacDonald   +13 more
doaj   +1 more source

Diuretics [PDF]

open access: yesThe American Journal of the Medical Sciences, 1898
n ...
openaire   +2 more sources

Rational pharmacotherapy of arterial hypertension in real clinical practice: diuretics through drug safety

open access: yes, 2023
The use of diuretics in arterial hypertension is pathogenetically justified, which is due to the significant role of an increase in the volume of circulating blood and the retention of sodium ions in the internal environment of the body, in increasing ...
Dmitry I. Trukhan, Natalya V. Bagisheva
core   +1 more source

Controlled arterial hypertension and adverse event free survival rate in heart recipients

open access: yesКардиоваскулярная терапия и профилактика, 2018
Aim. To evaluate the prevalence of arterial hypertension (AH) in heart transplant recipients, and its influence on the risk of adverse events, as the efficacy and safety of antihypertension medications (AHM).Material and methods.
A. О. Shevchenko   +4 more
doaj   +1 more source

Pharmacotherapy for Essential Hypertension: A Brief Review

open access: yesMethodist DeBakey Cardiovascular Journal, 2022
Hypertension is one of the leading causes of disability-adjusted life years and mortality, with approximately 15% prevalence worldwide. Most patients with hypertension from low- to high-income countries do not receive treatment.
Behnam Heidari   +2 more
doaj   +1 more source

Diuretics and Their Application

open access: yes, 2022
Reviewed in the literature of this thesis are the classes of diuretic drugs and their mechanism of action, the form of diuretic therapy taken depending on the kind of illness, the different drug interactions, and adverse effects different classes of ...
Akinmosin, Oladipo Samson
core  

Cardiovascular and Renal Outcomes with Ertugliflozin by Baseline Use of Renin-Angiotensin-Aldosterone System Inhibitors or Diuretics, Including Mineralocorticoid Receptor Antagonist: Analyses from the VERTIS CV Trial

open access: yesKidney Diseases
Introduction: VERTIS CV was a placebo-controlled cardiovascular (CV) outcome trial evaluating the sodium-glucose cotransporter 2 inhibitor ertugliflozin in patients with type 2 diabetes and established atherosclerotic CV disease.
David Z.I. Cherney   +10 more
doaj   +1 more source

Association of diuretics with falls and wrist fractures: a Mendelian randomization study

open access: yesFrontiers in Public Health
BackgroundThe association between diuretics and falls in older adult has been reported in previous studies, but discrepancy remains between the different types of diuretics.
Fei Liu   +5 more
doaj   +1 more source

Diuretics for hypertension from the perspective of novel clinical guidelines and meta-analyzes

open access: yesРоссийский кардиологический журнал, 2021
A review of the efficacy and safety of diuretics in hypertension was carried out from the standpoint of current clinical guidelines. Also, updated data from metaanalyzes of the efficacy and metabolic effects of diuretic therapy were reviewed.
S. V. Nedogoda
doaj   +1 more source

Home - About - Disclaimer - Privacy